Drugging the undruggable: targeting challenging E3 ligases for personalized medicine
This research article brought to MedChemNet users by our sister journal Future Medicinal Chemistry, discusses the challenges that surround attempting to target E3 ligases for personalized medicine.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.